MediPharm Labs (TSX:LABS) Other Long Term Assets : C$0.75 Mil (As of Sep. 2024)

View and export this data going back to 2018. Start your Free Trial

What is MediPharm Labs Other Long Term Assets?

MediPharm Labs's other long-term assets for the quarter that ended in Sep. 2024 was C$0.75 Mil.

MediPharm Labs's quarterly other long-term assets declined from Mar. 2024 (C$0.98 Mil) to Jun. 2024 (C$0.91 Mil) but then stayed the same from Jun. 2024 (C$0.91 Mil) to Sep. 2024 (C$0.75 Mil).

MediPharm Labs's annual other long-term assets declined from Dec. 2021 (C$0.88 Mil) to Dec. 2022 (C$0.00 Mil) but then increased from Dec. 2022 (C$0.00 Mil) to Dec. 2023 (C$1.00 Mil).

MediPharm Labs Other Long Term Assets Historical Data

The historical data trend for MediPharm Labs's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MediPharm Labs Other Long Term Assets Chart

MediPharm Labs Annual Data

Trend

Sep17

Sep18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Long Term Assets

Get a 7-Day Free Trial

6.71

2.15

0.88

1.00

MediPharm Labs Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Other Long Term Assets	Get a 7-Day Free Trial															-	1.00	0.98	0.91	0.75

MediPharm Labs Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

MediPharm Labs Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » MediPharm Labs Corp (TSX:LABS) » Definitions » Other Long Term Assets

Comparable Companies

Traded in Other Exchanges

MEDIF:USA MLZ:Germany

Address

151 John Street, Barrie, ON, CAN, L4N 2L1

Website

https://www.medipharmlabs.com

MediPharm Labs Corp is a pharmaceutical company specializing in precision-based cannabinoids. The Company operates in one reportable segment, the production and sales of cannabis flower, extracts, and derivative products. Through its wholesale and white-label platforms, MediPharm Labs formulates, develops, processes, packages, and distributes cannabis extracts and cannabinoid-based products to domestic and international markets. Geographically the company has a presence in Canada, Australia, Germany, and other countries and the majority of revenue derives from Canada.

Executives

Keith Strachan	Director
Gregory Edison Hunter	Senior Officer
David Pidduck	Director, Senior Officer
Bryan Howcroft	Director, Senior Officer
Patrick Mccutcheon	Director
Warren Everitt	Director or Senior Officer of Insider or Subsidiary (other than in 4,5,6)
Etf Managers Trust	10% Security Holder
Christopher David Taves	Director
Sybil Taylor	Senior Officer
Braden Fenske	Senior Officer
David John Mayers	Senior Officer